C-peptide1 EIA - Cosmo Bio Co.,Ltd.

Antibodies

>

C-peptide1 EIA

Catalog No.: YII-YK011-EX
Size: 1KIT
Price: ¥76000
$1014
antigen/source: C-Peptide 1
Application: Enzyme Immunoassay
catalog info: Catalog 2012-p110
Storage: 4C
@
Immunogen: Mouse
Reacts with: Mouse
Measurement Range: 0.617 - 50 ng/mL
Purpose: This ELISA kit is used for quantitative determination of mouse C-Peptide I in its plasma, serum & urine samples. The kit is characterized for sensitive quantification, high specificity and no influences with other components in samples. Mouse C-Peptide I standard of this kit is a highly purified synthetic product (purity: higher than 98%).
component: Antibody: X
Plate: X
Coating: X
Control: -
Standard: X
Labeling: X
Substrate: X
Others: X
1. Antibody coated plate 1 plate (96 wells)
2. C-Peptide I standard 1 vial
3. Labeled antigen 1 vial
4. C-Peptide I antibody 1 bottle (6 mL)
5. Buffer solution 1 bottle (20 mL)
6. SA-HRP solution 1 bottle (12 mL)
7. Substrate buffer 1 bottle (26 mL)
8. OPD tablet 2 tablets
9. Stopping solution 1M H2SO4 1 bottle (12 mL)
10. Washing solution 1 bottle (50 mL)
11. Acetate plate sealer 3 pieces

Other:

 Supplementary 
Competitive
 Applicable sample 
Serum, Plasma, Urine
[Other]
This enzyme immunoassay (EIA) kit is a stable and convenient assay system for mouse C-peptide I in its plasma, serum and urine.
The processing of proinsulin, which occurs within the B cell, yields insulin and C-peptide. The insulin and C-peptide are secreted in equimolar quantities into blood circulation. Therefore, the measurement of C-peptide in blood reflects the concentration of insulin and also provides valuable information to evaluate the pancreatic B cell function.
The EIA kit is prepared by using synthetic mouse C-Peptide I as standard antigen and biotinylated mouse C-Peptide I as labeled antigen. The kit contains specific polyclonal antibody recognized to the amino acid sequence of mouse C-Peptide I.
We have already developed mouse C-peptide II EIA kit and mouse C-peptide I+II kit is also been developing in our laboratory.


Reference:

•  Nobuya SHIRAI, Tomoyuki HIGUCHI and Hiramitsu SUZUKI Food Science and Technology Research. Vol. 14 (2008) ,No. 1 pp.25-31
•  Wahren, J. et al., Diabetes Metab. Res. Rev., 19 (5), 345-347, 2003
•  Pierson, CR. et al., J. Neuropathol. Exp. Neurol., 62 (7), 765-79, 2003
•  Li, ZG. et al., Diabetes Metab. Res. Rev., 19 (5), 375-85, 2003
5. Johansson, J. et al., Biochem. Biophy. Res. Comm., 295, 1035-1040, 2002
•  Lindon, H. et al.,, Am. J. Phsiol. Heart Circ. Physiol., 279 (4), 1453-1459, 2000
•  Matsuda M. and Oka, Y.. C-peptide (CPR), Nippon Rinsho Vol 57, 1999Suppl, Wide range blood.. urine chemical detection, Immunological Examination (4), 313-316, 1999
•  Wentworth, BM. et al., J. Mol. Evol., 23 (4), 305-312, 1986
9. Yanaihara, C. et al., In: Insulin (ed. Brandenburg, D., and Wollmer. A.), Walter de Gruyter &Co.,Berlin, 651-657, 1980
•  Yanaihara, C. et al., In: Proinsulin, Insulin, C-peptide (ed.Baba,S., Kaneko,S., and Yanaihara, N.), Excerpta Medica, Amsterdam-Oxford, 87-93, 1979
 
>